Baddi (Solan). In the investigation of Central Drugs Standard Control Organization (CDSCO), 24 medicines, syrups and injections manufactured in 19 pharmaceutical industries of Himachal have been found to be substandard. A total of 61 medicine samples across the country have failed. Medicines that have not met the quality standards include fungal infections, cancer, type 2 diabetes, serious bacterial infections, cardiac arrest, antibiotics, respiratory diseases, anti-inflammatory drugs, angina, Alzheimer’s, antiparasitic, stomach ulcers, fever. Includes medicines used in the treatment of pain.
These medicines are manufactured in the pharmaceutical industries located at Baddi, Barotiwala, Waknaghat in Solan district of Himachal Pradesh and Paonta Sahib in Sirmaur district. Five samples of Effie Pharma Industry located in Baddi have failed. The State Drug Control Authority has already taken action against this industry and banned the production of the drug.
In the drug alert for the month of October issued by CDSCO, 37 medicines manufactured in New Delhi, Jammu, Rajasthan, Bihar, Uttarakhand, Bangalore, Kolkata, Uttar Pradesh, Punjab, Rajasthan, Gujarat, Maharashtra, Chennai have also been found to be substandard. The State Drug Controller immediately took action and issued notices to all the pharmaceutical companies included in the drug alert and issued instructions to immediately recall the entire batch of the concerned medicine from the market. Along with this, assistant drug controllers have been instructed to conduct joint inspection of all the pharmaceutical industries and submit a detailed investigation report.
Notice issued to companies – Officer
State Drug Controller Navneet Marwah said that show cause notices have been issued to all the concerned pharmaceutical companies included in the drug alert for the month of October issued by CDSCO and instructions have been given to recall the entire stock of the concerned batch. Apart from this, strict action will be taken against those industries whose samples are repeatedly failing.
FIRST PUBLISHED: November 21, 2023, 13:18 IST